This prompted us to explore the potential of serum IL-6 as a diagnostic biomarker for AIS patients.In a subsequent analysis of 300 retrospective serum samples including 100 AIS, 100 BPN, and 100 HC samples, we obtained the expected results. The gene discussed is IL6; the disease is androgen insensitivity syndrome.